Dongyang Jiang

Dr. Dongyang Jiang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
LMLijie Mao
Lijie Mao
JLJi Lu
Ji Lu
XWXinyu Wen
Xinyu Wen
ZSZhiyi Song
Zhiyi Song
CSCai Sun
Cai Sun
JSJianlin Shi
Jianlin Shi
This review explores the mechanisms and rational designs of nanomaterial-mediated cuproptosis and its innovative nanotherapeutic strategies in cancer and other potential applications, highlighting the targeted therapies and clinical potential.

12 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
QLQinyuan Liao
Qinyuan Liao
WLWei Liu
Wei Liu
YLYang Liu
Yang Liu
FWFulin Wang
Fulin Wang
CWChong Wang
Chong Wang
XQXiaoyan Qiu
Xiaoyan Qiu
Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis

Verified
Journal Article
Open access
PDF file
DJDongyang Jiang
Dongyang Jiang
JGJing Ge
Jing Ge
QLQinyuan Liao
Qinyuan Liao
JMJunfan Ma
Junfan Ma
YLYang Liu
Yang Liu
XQXiaoyan Qiu
Xiaoyan Qiu
The innate immune system of the skin is thought to depend largely on a multi-layered mechanical barrier supplemented by epidermis-derived antimicrobial peptides. To date, there are no reports of antimicrobial antibody secretion by the epidermis. In this study, we report the expression of functional immunoglobulin G (IgG) and immunoglobulin A (IgA), previously thought to be only produced by B cells, in normal human epidermal cells and the human keratinocyte line HaCaT. While B cells express a fully diverse Ig, epidermal cell-expressed IgG or IgA showed one or two conservative VHDJH rearrangements in each individual. These unique VDJ rearrangements in epidermal cells were found neither in the B cell-derived Ig VDJ databases published by others nor in our positive controls. IgG and IgA from epidermal cells of the same individual had different VDJ rearrangement patterns. IgG was found primarily in prickle cells, and IgA was mainly detected in basal cells. Both epidermal cell-derived IgG and IgA showed potential antibody activity by binding pathogens like Staphylococcus aureus, the most common pathogenic skin bacteria, but the microbial-binding profile was different. Our data indicates that normal human epidermal cells spontaneously express IgG and IgA, and we speculate that these Igs participate in skin innate immunity.

9 March 2015 in Histopathology
Verified
Journal Article
Closed access
PDF file
YLYang Liu
Yang Liu
DLDan Liu
Dan Liu
CWChong Wang
Chong Wang
QLQinyuan Liao
Qinyuan Liao
JHJing Huang
Jing Huang
XQXiaoyan Qiu
Xiaoyan Qiu

1 August 2023 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
DJDongyang Jiang
Dongyang Jiang
HLHao Liu
Hao Liu
GZGuofu Zhu
Guofu Zhu
XLXiankai Li
Xiankai Li
LFLinlin Fan
Linlin Fan
JPJinjiang Pang
Jinjiang Pang
BACKGROUND: Numerous genome-wide association studies revealed that SNPs (single nucleotide polymorphisms) at the PHACTR1 (phosphatase and actin regulator 1) locus strongly correlate with coronary artery disease. However, the biological function of PHACTR1 remains poorly understood. Here, we identified the proatherosclerotic effect of endothelial PHACTR1, contrary to macrophage PHACTR1. METHODS: We generated global ( Phactr1 −/− ) and endothelial cell (EC)–specific ( Phactr1 ECKO ) Phactr1 KO (knockout) mice and crossed these mice with apolipoprotein E–deficient ( Apoe −/− ) mice. Atherosclerosis was induced by feeding the high-fat/high-cholesterol diet for 12 weeks or partially ligating carotid arteries combined with a 2-week high-fat/high-cholesterol diet. PHACTR1 localization was identified by immunostaining of overexpressed PHACTR1 in human umbilical vein ECs exposed to different types of flow. The molecular function of endothelial PHACTR1 was explored by RNA sequencing using EC-enriched mRNA from global or EC-specific Phactr1 KO mice. Endothelial activation was evaluated in human umbilical vein ECs transfected with siRNA targeting PHACTR1 and in Phactr1 ECKO mice after partial carotid ligation. RESULTS: Global or EC-specific Phactr1 deficiency significantly inhibited atherosclerosis in regions of disturbed flow. PHACTR1 was enriched in ECs and located in the nucleus of disturbed flow areas but shuttled to cytoplasm under laminar flow in vitro. RNA sequencing showed that endothelial Phactr1 depletion affected vascular function, and PPARγ (peroxisome proliferator-activated receptor gamma) was the top transcription factor regulating differentially expressed genes. PHACTR1 functioned as a PPARγ transcriptional corepressor by binding to PPARγ through the corepressor motifs. PPARγ activation protects against atherosclerosis by inhibiting endothelial activation. Consistently, PHACTR1 deficiency remarkably reduced endothelial activation induced by disturbed flow in vivo and in vitro. PPARγ antagonist GW9662 abolished the protective effects of Phactr1 KO on EC activation and atherosclerosis in vivo. CONCLUSIONS: Our results identified endothelial PHACTR1 as a novel PPARγ corepressor to promote atherosclerosis in disturbed flow regions. Endothelial PHACTR1 is a potential therapeutic target for atherosclerosis treatment.

5 November 2021 in Hypertension
Verified
Journal Article
Closed access
PDF file
SWShumin Wang
Shumin Wang
GZGuofu Zhu
Guofu Zhu
DJDongyang Jiang
Dongyang Jiang
JRJordan Rhen
Jordan Rhen
XLXiankai Li
Xiankai Li
JPJinjiang Pang
Jinjiang Pang
Clinical trials of Dll4 (Delta-like 4) neutralizing antibodies (Dll4nAbs) in cancer patients are ongoing. Surprisingly, pulmonary hypertension (PH) occurs in 14% to 18% of patients treated with Dll4nAbs, but the mechanisms have not been studied. Here, PH progression was measured in mice treated with Dll4nAbs. We detected Notch signaling in lung tissues and analyzed pulmonary vascular permeability and inflammation. Notch target gene array was performed on adult human pulmonary microvascular endothelial cells (ECs) after inhibiting Notch cleavage. Similar mechanisms were studied in PH mouse models and pulmonary arterial hypertension patients. The rescue effects of constitutively activated Notch1 in vivo were also measured. We observed that Dll4nAbs induced PH in mice as indicated by significantly increased right ventricular systolic pressure, as well as pulmonary vascular and right ventricular remodeling. Mechanistically, Dll4nAbs inhibited Notch1 cleavage and subsequently impaired lung endothelial barrier function and increased immune cell infiltration in vessel walls. In vitro, Notch targeted genes’ expression related to cell growth and inflammation was decreased in human pulmonary microvascular ECs after the Notch1 inactivation. In lungs of PH mouse models and pulmonary arterial hypertension patients, Notch1 cleavage was inhibited. Consistently, EC cell-cell junction was leaky, and immune cell infiltration increased in PH mouse models. Overexpression activated Notch1-attenuated progression of PH in mice. In conclusion, Dll4nAbs led to PH development in mice by impaired EC barrier function and increased immune cell infiltration through inhibition of Notch1 cleavage in lung ECs. Reduced Notch1 cleavage in lung ECs could be an underlying mechanism of PH pathogenesis.